President Trump has signed an executive order aimed at boosting the U.S. pharma supply chain. Peter Navarro, White House senior counselor for trade and manufacturing, discusses its effects.
Breakdown
- President Trump signed an executive order to strengthen the U.S. pharma supply chain.
- The order establishes a reserve of active pharmaceutical ingredients (APIs) and a list of critical drugs. 4s
- Government agencies will issue long-term contracts to support domestic drug manufacturing. 52s
- The order aims to reduce U.S. reliance on pharmaceutical imports from China and India. 1m 52s
- Potential pharmaceutical tariffs are anticipated following a Department of Commerce review. 2m 29s